Nucleic acid and corresponding protein entitled 193P1E1B...

Details Nucleic acid and corresponding protein entitled 193P1E1B... Nucleic acid and corresponding protein entitled 193P1E1B...

2001-12-07

2008-11-11

Yu, Misook (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Reexamination Certificate

active

07449548

ABSTRACT:
A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 193P1E1B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 193P1E1B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 191P1E1B can be used in active or passive immunization.

REFERENCES:
patent: 5643778 (1997-07-01), Nishikura
patent: 5840839 (1998-11-01), Wang et al.
patent: 1 308 459 (2003-05-01), None
patent: WO9839446 (1998-09-01), None
patent: WO9845435 (1998-10-01), None
patent: WO9906548 (1999-02-01), None
patent: WO9931236 (1999-06-01), None
patent: WO9938972 (1999-08-01), None
patent: WO9958675 (1999-11-01), None
patent: WO0018916 (2000-04-01), None
patent: WO0021991 (2000-04-01), None
patent: WO-01/12811 (2001-02-01), None
patent: WO0122920 (2001-04-01), None
patent: WO0142302 (2001-06-01), None
patent: WO0142451 (2001-06-01), None
patent: WO0160860 (2001-08-01), None
patent: WO-01/90157 (2001-11-01), None
patent: WO0229086 (2002-04-01), None
patent: WO0240718 (2002-05-01), None
patent: WO0248337 (2002-06-01), None
patent: WO02074961 (2002-09-01), None
patent: WO02085298 (2002-10-01), None
Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, p. 465).
Shantz and Pegg (Int J of Biochem and Cell Biol., 1999, vol. 31, pp. 107-122).
McClean and Hill (Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248).
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401).
Bussenmakers et al., Cancer Res. Dec. 1, 1999;59 :5975-79.
Scott et al (Nature Genetics, 1999, 21:440-443).
Skolnick et al. (2000, Trends in Biotech. 18:34-39).
Bork (2000, Genome Research 10:398-400).
Doerks et al. (1998, Trends in Genetics 14:248-250).
Smith et al. (1997, Nature Biotechnology 15:1222-1223).
Brenner (1999, Trends in Genetics 15:132-133).
Bork et al. (1996, Trends in Genetics 12:425-427).
Bowie et al. (1990, Science 247:1306-1310).
Sherman, LA et al, 1998, Critical reviews in Immunol, 18(1-2): 47-54.
Lauritzsen et al (International Journal of Cancer, 1998, vol. 78, pp. 216-222).
Sarma et al (Journal of Experimental Medicine, 1999, vol. 189, pp. 811-820).
Ezzell (J. NIH Res, 1995, 7:46-49).
Spitler (Cancer Biotherapy, 1995, 10: 1-3).
Boon (Adv Can Res, 1992, 58:177-210).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39).
Wang et al., J Biol Chem. Aug. 29, 1997;272 (35):22227-35.
NCBI Accession No. BC013418 (Sep. 4, 2001).
Broder et al., Curr Opin Biotechnol. Dec. 2000; 11(6):581-5.
Benjamini and Leskowitz (1993, Immunology, 2nd edition, Chapter 3 only, pp. 37-45).
You et al., Neoplasia. Jun. 2007; 9(6): 464-470.
International Search Report for PCT/US02/39274, mailed on Oct. 6, 2004, 3 pages.
Ota et al., Nat. Genet. (2004) 36(1):40-45.
Shibata et al., Genome Res. (2000) 10(11):1757-1771.
Thai et al., Adv. Immunol. (2005) 86:113-136 (abstract only).
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
Database EMBL, EBI accession No. EMBL:BC013418 (2001).
Database EMBL, EBI accession No. EMBL:BG392826 (2001).
Database EMBL, EBI accession No. EMBL:AL561096 (2001).
Database EMBL, EBI accession No. EMBL:AL519504 (2001).
Database EMBL, EBI accession No. EMBL:AK090584 (2002).
Supplementary Partial European Search Report for EP 02797238.9, mailed Oct. 12, 2007, 7 pages.
Hubert et al., PNAS USA (1999) 96(25):14523-14528.
Japanese Office Action for Application No. 2003-551277, mailed on Feb. 15, 2008, 7 pages.
Klein et al., Nature Medicine (1997) 3(4):402-408.

Affiliated with

Also associated with

Rating

Nucleic acid and corresponding protein entitled 193P1E1B... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid and corresponding protein entitled 193P1E1B..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 193P1E1B... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4039052